{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T02:58:28Z","timestamp":1761101908279},"publisher-location":"Chichester, UK","reference-count":44,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd008005.pub2","type":"reference-entry","created":{"date-parts":[[2010,6,15]],"date-time":"2010-06-15T16:02:28Z","timestamp":1276617748000},"source":"Crossref","is-referenced-by-count":7,"title":["Sapropterin dihydrochloride for phenylketonuria"],"prefix":"10.1002","author":[{"given":"Usha Rani","family":"Somaraju","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcus","family":"Merrin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2010,6,16]]},"reference":[{"key":"10.1002\/14651858.CD008005.pub2-BIB1|cit1","doi-asserted-by":"crossref","unstructured":"Lee P Treacy EP Crombez E Wasserstein M Waber L Wolff J Safety and efficacy of 22 weeks of treatment with sapropterin dihydrochloride in patients with phenylketonuria American Journal of Medical Genetics. Part A 2008 2851 9","DOI":"10.1002\/ajmg.a.32562"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD008005.pub2-BIB2|cit2","first-page":"13","article-title":"A phase 3 study of the efficacy of sapropterin in reducing phe levels in subjects with phenylketonuria [abstract]","volume":"29","author":"Levy","year":"2006","journal-title":"Journal of Inherited Metabolic Disease"},{"issue":"9586","key":"10.1002\/14651858.CD008005.pub2-BIB3|cit3","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/S0140-6736(07)61234-3","article-title":"Efficacy of sapropterin dihydrochloride (tetrahydrobiopterin, 6R-BH4) for reduction of phenylalanine concentration in patients with phenylketonuria: a phase III randomised placebo-controlled study","volume":"370","author":"Levy","year":"2007","journal-title":"Lancet"},{"issue":"5","key":"10.1002\/14651858.CD008005.pub2-BIB4|cit4","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.jpeds.2008.11.040","article-title":"Efficacy of sapropterin dihydrochloride in increasing phenylalanine tolerance in children with phenylketonuria: a phase III, randomized, double-blind, placebo-controlled study","volume":"154","author":"Trefz","year":"2009","journal-title":"Journal of Pediatrics"},{"issue":"6 Suppl 1","key":"10.1002\/14651858.CD008005.pub2-BIB5|cit5","doi-asserted-by":"crossref","first-page":"1561S","DOI":"10.1093\/jn\/137.6.1561S","article-title":"Management of phenylketonuria and hyperphenylalaninemia","volume":"137","author":"Baulny","year":"2007","journal-title":"Journal of Nutrition"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD008005.pub2-BIB6|cit6","doi-asserted-by":"crossref","first-page":"S61","DOI":"10.1016\/j.ymgme.2005.07.024","article-title":"Spanish BH4-responsive phenylalanine hydroxylase-deficient patients: evolution of seven patients on long-term treatment with tetrahydrobiopterin","volume":"86","author":"Belanger-Quintana","year":"2005","journal-title":"Molecular Genetics and Metabolism"},{"issue":"4","key":"10.1002\/14651858.CD008005.pub2-BIB7|cit7","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/S1096-7192(02)00171-3","article-title":"High frequency of tetrahydrobiopterin-responsiveness among hyperphenylalaninemias: a study of 1919 patients observed from 1988 to 2002","volume":"77","author":"Bernegger","year":"2002","journal-title":"Molecular Genetics and Metabolism"},{"issue":"2","key":"10.1002\/14651858.CD008005.pub2-BIB8|cit8","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ymgme.2004.03.006","article-title":"The metabolic and molecular bases of tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency","volume":"82","author":"Blau","year":"2004","journal-title":"Molecular Genetics and Metabolism"},{"issue":"5","key":"10.1002\/14651858.CD008005.pub2-BIB9|cit9","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1007\/s10545-007-0567-1","article-title":"The tetrahydrobiopterin loading test in 36 patients with hyperphenylalaninemia: evaluation of response and subsequent treatment","volume":"30","author":"Boveda","year":"2007","journal-title":"Journal of Inherited Metabolic Disease"},{"issue":"1","key":"10.1002\/14651858.CD008005.pub2-BIB10|cit10","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s10545-008-0947-1","article-title":"Effect of BH(4) supplementation on phenylalanine tolerance","volume":"32","author":"Burlina","year":"2009","journal-title":"Journal of Inherited Metabolic Disease"},{"key":"10.1002\/14651858.CD008005.pub2-BIB11|cit11","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1007\/s10545-007-0605-z","article-title":"The response of patients with phenylketonuria and elevated serum phenylalanine to treatment with oral sapropterin dihydrochloride (6R-tetrahydrobiopterin): a phase II, multicentre, open-label, screening study","volume":"30","author":"Burton","year":"2007","journal-title":"Journal of Inherited Metabolic Disease"},{"issue":"2","key":"10.1002\/14651858.CD008005.pub2-BIB12|cit12","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ymgme.2003.11.008","article-title":"Long-term follow-up of a patient with mild tetrahydrobiopterin-responsive phenylketonuria","volume":"81","author":"Cerone","year":"2004","journal-title":"Molecular Genetics and Metabolism"},{"issue":"3","key":"10.1002\/14651858.CD008005.pub2-BIB13|cit13","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1136\/adc.2006.104786","article-title":"Effects of dietary management of phenylketonuria on long-term cognitive outcome","volume":"92","author":"Channon","year":"2007","journal-title":"Archives of Disease in Childhood"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD008005.pub2-BIB14|cit14","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/PL00014228","article-title":"Recommendations for protein and amino acid intake in phenylketonuric patients","volume":"155","author":"Cockburn","year":"1996","journal-title":"European Journal of Pediatrics"},{"issue":"1","key":"10.1002\/14651858.CD008005.pub2-BIB15|cit15","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/ije\/31.1.140","article-title":"Meta-analyses involving cross-over trials: methodological issues","volume":"31","author":"Elbourne","year":"2002","journal-title":"International Journal of Epidemiology"},{"issue":"48","key":"10.1002\/14651858.CD008005.pub2-BIB16|cit16","doi-asserted-by":"crossref","first-page":"16903","DOI":"10.1073\/pnas.0407256101","article-title":"Correction of kinetic and stability defects by tetrahydrobiopterin in phenylketonuria patients with certain phenylalanine hydroxylase mutations","volume":"101","author":"Erlandsen","year":"2004","journal-title":"Proceedings of National Academy of Science USA"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD008005.pub2-BIB17|cit17","doi-asserted-by":"crossref","first-page":"S91","DOI":"10.1016\/j.ymgme.2005.09.014","article-title":"Extended tetrahydrobiopterin loading test in the diagnosis of cofactor-responsive phenylketonuria: a pilot study","volume":"86","author":"Fiege","year":"2005","journal-title":"Molecular Genetics and Metabolism"},{"issue":"6","key":"10.1002\/14651858.CD008005.pub2-BIB18|cit18","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.jpeds.2007.02.017","article-title":"Assessment of tetrahydrobiopterin responsiveness in phenylketonuria","volume":"150","author":"Fiege","year":"2007","journal-title":"Journal of Pediatrics"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD008005.pub2-BIB19|cit19","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.1016\/j.ymgme.2005.06.017","article-title":"Incidence of BH4-responsiveness in phenylalanine-hydroxylase-deficient Italian patients","volume":"86","author":"Fiori","year":"2005","journal-title":"Molecular Genetics and Metabolism"},{"issue":"2","key":"10.1002\/14651858.CD008005.pub2-BIB20|cit20","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s10545-007-0552-8","article-title":"Phenylketonuria: Dietary and therapeutic challenges","volume":"30","author":"Giovanni","year":"2007","journal-title":"Journal of Inherited Metabolic Disease"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD008005.pub2-BIB21|cit21","doi-asserted-by":"crossref","first-page":"S86","DOI":"10.1016\/j.ymgme.2005.05.013","article-title":"Long-term treatment with tetrahydrobiopterin increases phenylalanine tolerance in children with severe phenotype of phenylketonuria","volume":"86","author":"Hennermann","year":"2005","journal-title":"Molecular Genetics and Metabolism"},{"issue":"7414","key":"10.1002\/14651858.CD008005.pub2-BIB22|cit22","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD008005.pub2-BIB23|cit23","unstructured":"Higgins JPT Altman DG Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions. Version 5.0.0 (updated February 2008) The Cochrane Collaboration, 2008. Available from www.cochrane-handbook.org"},{"issue":"5","key":"10.1002\/14651858.CD008005.pub2-BIB24|cit24","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1023\/A:1020158631102","article-title":"Phenylketonuria in adulthood: a collaborative study","volume":"25","author":"Koch","year":"2002","journal-title":"Journal of Inherited Metabolic Disease"},{"issue":"3","key":"10.1002\/14651858.CD008005.pub2-BIB25|cit25","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0022-3476(99)70138-1","article-title":"Tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency","volume":"135","author":"Kure","year":"1999","journal-title":"Journal of Pediatrics"},{"issue":"1","key":"10.1002\/14651858.CD008005.pub2-BIB26|cit26","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/s10545-006-0096-3","article-title":"The spectrum of phenylalanine variations under tetrahydrobiopterin load in subjects affected by phenylalanine hydroxylase deficiency","volume":"29","author":"Leuzzi","year":"2006","journal-title":"Journal of Inherited Metabolic Disease"},{"issue":"1","key":"10.1002\/14651858.CD008005.pub2-BIB27|cit27","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1006\/mgme.2001.3168","article-title":"Tetrahydrobiopterin responsiveness in phenylketonuria differs between patients with the same genotype","volume":"73","author":"Lindner","year":"2001","journal-title":"Molecular Genetics and Metabolism"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD008005.pub2-BIB28|cit28","first-page":"23","article-title":"Tetrahydrobiopterin-responsive phenylalanine hydroxylase mutations","volume":"25","author":"Matalon","year":"2002","journal-title":"Journal of Inherited Metabolic Disease"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD008005.pub2-BIB29|cit29","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1016\/j.ymgme.2005.06.024","article-title":"Response of patients with phenylketonuria in the US to tetrahydrobiopterin","volume":"86","author":"Matalon","year":"2005","journal-title":"Molecular Genetics and Metabolism"},{"issue":"6 Suppl 1","key":"10.1002\/14651858.CD008005.pub2-BIB30|cit30","doi-asserted-by":"crossref","first-page":"1564S","DOI":"10.1093\/jn\/137.6.1564S","article-title":"Response of phenylketonuria to tetrahydrobiopterin","volume":"137","author":"Michals-Matalon","year":"2007","journal-title":"Journal of Nutrition"},{"issue":"6870","key":"10.1002\/14651858.CD008005.pub2-BIB31|cit31","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1136\/bmj.306.6870.115","article-title":"Phenylketonuria due to phenylalanine hydroxylase deficiency: an unfolding story","volume":"306","year":"1993","journal-title":"BMJ"},{"issue":"26","key":"10.1002\/14651858.CD008005.pub2-BIB32|cit32","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1056\/NEJMoa021654","article-title":"Tetrahydrobiopterin as an alternative treatment for mild phenylketonuria","volume":"347","author":"Muntau","year":"2002","journal-title":"New England Journal of Medicine"},{"issue":"4","key":"10.1002\/14651858.CD008005.pub2-BIB33|cit33","first-page":"972","article-title":"National Institutes of Health Consensus Development Conference statement: phenylketonuria: screening and management","volume":"108","year":"2000","journal-title":"Pediatrics"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD008005.pub2-BIB34|cit34","first-page":"29","article-title":"A patient with phenylketonuria successfully treated with tetrahydrobiopterin","volume":"24","author":"Nuoffer","year":"2001","journal-title":"Journal of Inherited Metabolic Disease"},{"key":"10.1002\/14651858.CD008005.pub2-BIB35|cit35","first-page":"1667","article-title":"Hyperphenylalaninemia : Phenylalanine Hydroxylase Deficiency","volume-title":"The Metabolic and Molecular Bases of Disease","volume":"2","author":"Scriver","year":"2001"},{"issue":"9","key":"10.1002\/14651858.CD008005.pub2-BIB36|cit36","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1002\/humu.20526","article-title":"The PAH gene, phenylketonuria, and a paradigm shift","volume":"28","author":"Scriver","year":"2007","journal-title":"Human Mutation"},{"issue":"3","key":"10.1002\/14651858.CD008005.pub2-BIB37|cit37","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1203\/01.PDR.0000111283.91564.7E","article-title":"Long-term treatment and diagnosis of tetrahydrobiopterin-responsive hyperphenylalaninemia with a mutant phenylalanine hydroxylase gene","volume":"55","author":"Shintaku","year":"2004","journal-title":"Pediatric Research"},{"issue":"3","key":"10.1002\/14651858.CD008005.pub2-BIB38|cit38","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1023\/A:1010596317296","article-title":"Tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency in Ditch neonates","volume":"24","author":"Spaapen","year":"2001","journal-title":"Journal of Inherited Metabolic Disease"},{"issue":"7","key":"10.1002\/14651858.CD008005.pub2-BIB39|cit39","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s00431-002-0966-0","article-title":"Tetrahydrobipterin monotherapy for phenylketonuria patients with common mild mutations","volume":"161","author":"Steinfeld","year":"2002","journal-title":"European Journal of Pediatrics"},{"issue":"1","key":"10.1002\/14651858.CD008005.pub2-BIB40|cit40","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s00726-002-0354-0","article-title":"A hypothesis on the biochemical mechanism of BH(4) -responsiveness in phenylalanine hydroxylase deficiency","volume":"25","author":"Steinfeld","year":"2003","journal-title":"Amino Acids"},{"issue":"4","key":"10.1002\/14651858.CD008005.pub2-BIB41|cit41","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1023\/B:BOLI.0000037351.10132.99","article-title":"Efficiency of long-term tetrahydrobiopterin monotherapy in phenylketonuria","volume":"27","author":"Steinfeld","year":"2004","journal-title":"Journal of Inherited Metabolic Disease"},{"issue":"5","key":"10.1002\/14651858.CD008005.pub2-BIB42|cit42","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/PL00008436","article-title":"Successful treatment of phenylketonuria with tetrahydrobiopterin","volume":"160","author":"Trefz","year":"2001","journal-title":"European Journal of Pediatrics"},{"issue":"6","key":"10.1002\/14651858.CD008005.pub2-BIB43|cit43","doi-asserted-by":"crossref","first-page":"e68","DOI":"10.1542\/peds.104.6.e68","article-title":"Management of phenylketonuria for optimal outcome: a review of guidelines for phenylketonuria management and a report of surveys of parents, patients, and clinic directors","volume":"104","author":"Wappner","year":"1999","journal-title":"Pediatrics"},{"issue":"1","key":"10.1002\/14651858.CD008005.pub2-BIB44|cit44","first-page":"31","article-title":"Phenylketonuria: an inborn error of phenylalanine metabolism","volume":"29","author":"Williams","year":"2008","journal-title":"Clinical Biochemist Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD008005.pub2\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T22:16:04Z","timestamp":1628547364000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD008005.pub2"}},"subtitle":[],"editor":[{"given":"Usha Rani","family":"Somaraju","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2010,6,16]]},"references-count":44,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd008005.pub2","relation":{},"subject":[],"published":{"date-parts":[[2010,6,16]]}}}